The effects of enteral artificial amniotic fluid-containing erythropoietin on short term outcomes of preterm infants

The effects of enteral artificial amniotic fluid-containing erythropoietin on short term outcomes of preterm infants


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: محمدباقر حسینی , سینا رئیسی , میثم بهتری , هادی ولیزاده , رویا صبوحی خامنه , حمید اعظم پور

کلمات کلیدی: amniotic fluid; erythropoietin; necrotizing enterocolitis; preterm infant

نشریه: 34107 , 3 , 61 , 2019

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله سینا رئیسی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات سلامت کودکان
کد مقاله 71242
عنوان فارسی مقاله The effects of enteral artificial amniotic fluid-containing erythropoietin on short term outcomes of preterm infants
عنوان لاتین مقاله The effects of enteral artificial amniotic fluid-containing erythropoietin on short term outcomes of preterm infants
ناشر 6
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Necrotizing Enterocolitis (NEC) is a common devastating gastrointestinal disease, which usually develops in premature infants. Erythropoietin (EPO) as a hematopoietic hormone produced by the kidney can also be naturally found in amniotic fluid and breast milk. There is some evidence that supports the contribution of EPO in the prevention of inflammation and intestinal tissue repair. This study was aimed to determine if oral administration of artificial amniotic fluid with or without EPO would protect preterm infants against NEC and improve the certain neonatal outcomes. In this study, 150 preterm infants with gestational age 28 weeks or less and birth weight 1250 grams or less were enrolled. The infants were divided randomly into 3 groups: 1) Control group (n=50) with routine feeding protocol without any administration; 2) Amniotic fluid group (n=50) with 5mL/kg synthetic amniotic fluid; 3) EPO group (n=50) with RhuEPO dissolved in the synthetic amniotic fluid. The administrations of the study solution were started 3 days after the birth and were continued for 3 weeks (21 days). The infants in the study groups were followed up until discharge and the frequency of NEC, mortality, and other complications of the disease among the groups were compared. The mortality rate in preterm infants of the amniotic fluid and EPO groups were significantly lower than in the control group (p=0.027). We couldn’t find any significant differences in the frequency of NEC and other complications among the three study groups. The administration of synthetic amniotic fluid (with or without EPO) in preterm infants may decrease the mortality rate. Use of EPO in synthetic amniotic fluid did not affect the frequency of NEC.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
محمدباقر حسینیاول
سینا رئیسیسوم
میثم بهتریچهارم
هادی ولیزادهپنجم
رویا صبوحی خامنهششم
حمید اعظم پوردوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
pdf_TJP_1971.pdf1398/12/05545540دانلود